# Orix Corp: financial statements, quarterly

IX · NYSE · CIK 1070304 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/ix.md) · [Financials](/companies/ix/financials.md) · [Filings](/companies/ix/filings.md) · [Insiders](/companies/ix/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ix/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2009-03-31) | FY2009 (2010-03-31) | FY2010 (2011-03-31) | FY2011 (2012-03-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.9](/filings/0001193125-10-149108.md) | [7.7](/filings/0001193125-11-172757.md) | [8.9](/filings/0001193125-12-284534.md) | [9.6](/filings/0001193125-12-284534.md) |
| Total assets | $bn | not reported | [83.2](/filings/0001193125-10-149108.md) | [103](/filings/0001193125-11-172757.md) | [102](/filings/0001193125-12-284534.md) |
| Total liabilities | $bn | not reported | [68.7](/filings/0001193125-10-149108.md) | [86.7](/filings/0001193125-11-172757.md) | [83.7](/filings/0001193125-12-284534.md) |
| Long-term debt | $bn | not reported | [41.2](/filings/0001193125-10-149108.md) | [54.5](/filings/0001193125-11-172757.md) | [51.9](/filings/0001193125-12-284534.md) |
| Short-term borrowings | $bn | not reported | [6.2](/filings/0001193125-10-149108.md) | [5.8](/filings/0001193125-11-172757.md) | [5.6](/filings/0001193125-12-284534.md) |
| Shareholders' equity | $bn | [12.7](/filings/0001193125-10-149108.md) | [14.0](/filings/0001193125-10-149108.md) | [15.9](/filings/0001193125-11-172757.md) | [17.0](/filings/0001193125-12-284534.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

Shares outstanding: 1,124,106,624 at 2026-03-31, from the cover of the [20-F filed 2026-06-22](/filings/0001193125-26-276640.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.